Product Details
Product Name:
Bergaptol |
CAS No.:
486-60-2 |
Purity:
99.92% |
Supply Ability:
10g |
Release date:
2024/11/13 |
Product Introduction
Bioactivity
名稱 | Bergaptol |
描述 | 1. Bergaptol (4-Hydroxybergapten) shows very good radical scavenging activity. 2. Bergaptol is a potent inhibitor of debenzylation activity of CYP3A4 enzyme. |
存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 37 mg/mL (183 mM)
|
關(guān)鍵字 | Bergaptol | Inhibitor | inhibit | CYPs | Cytochrome P450 |
相關(guān)產(chǎn)品 | Tebuconazole | 1-Ethynylnaphthalene | Diflubenzuron | Apigenin | Gemfibrozil | Fenofibrate | 1-Aminobenzotriazole | Methoxsalen | Naringin | Naringenin | Tauroursodeoxycholate | Doxepin hydrochloride |
相關(guān)庫(kù) | 抗癌天然產(chǎn)物庫(kù) | 經(jīng)典已知活性庫(kù) | 植物來(lái)源化合物庫(kù) | 抑制劑庫(kù) | 高通量篩選天然產(chǎn)物庫(kù) | 抗衰老化合物庫(kù) | 已知活性化合物庫(kù) | 古代經(jīng)典名方目錄分子庫(kù) | 藥食同源庫(kù) | 抗癌活性化合物庫(kù) |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
-
CAS:2524-37-0
$30.00 / 50mg
-
CAS:24512-63-8
$60.00 / 100mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$0.00/20mg |
|
Shanghai Standard Technology Co., Ltd.
|
2020-08-13 |
|
$9.80/1.8KG |
VIP5Y
|
Career Henan Chemical Co
|
2020-01-08 |
|
$0.00/1g |
VIP5Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2020-01-06 |